KRAS and pancreatic neoplasm: SETD2 is a suppressor gene of K-Ras-associated pancreatic cancer, and its loss in acinar cells promotes K-RAS-induced pancreatic ductal reprogramming through epigenetic dysregulation of Fbxw7.